Weng Tao

Dr. Tao is a biotech executive with over 20 years of experience in cellular and biologics therapeutic development for unmet medical needs. Prior to joining OncoImmune, Dr. Tao co-founded Neurotech USA in 2000, and served as its Chief Scientific Officer and Vice President for Research and Development, leading the development of their Encapsulated Cell Technology (ECT) from lab concept to clinical testing for a wide range of currently untreatable or under treated diseases, including RP, GA, MacTel and wet AMD. Dr. Tao then went on to start her own biotech consulting company, Tao Consulting LLC. She has broad experience in translational research, clinical development and regulatory affairs and a proven track record in team building, project management and problem solving utilizing multidisciplinary approaches.